JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression
出版年份 2013 全文链接
标题
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 44, Issue 2, Pages 591-599
出版商
Spandidos Publications
发表日期
2013-12-05
DOI
10.3892/ijo.2013.2209
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O 6 -methylguanine DNA methyltransferase promoter methylation via c-Myc signaling
- (2013) Ilya V. Pyko et al. CARCINOGENESIS
- The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- (2013) Florian A. Siebzehnrubl et al. EMBO Molecular Medicine
- Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells and their levels are inversely related to survival in patients with malignant gliomas
- (2012) C Ciceroni et al. CELL DEATH AND DIFFERENTIATION
- Selective killing of p53-deficient cancer cells by SP600125
- (2012) Mohamed Jemaà et al. EMBO Molecular Medicine
- A negative regulator or just an unconcerned passerby: phosphoinositide 3-kinase signalling in IL-12 production
- (2012) K. Miyazawa JOURNAL OF BIOCHEMISTRY
- ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells
- (2012) Aditi Nadkarni et al. JOURNAL OF NEURO-ONCOLOGY
- STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
- (2012) Shinji Kohsaka et al. MOLECULAR CANCER THERAPEUTICS
- c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells
- (2012) C-H Yoon et al. ONCOGENE
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- Targeting JNK for therapeutic depletion of stem-like glioblastoma cells
- (2012) Ken-ichiro Matsuda et al. Scientific Reports
- Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
- (2012) Atsushi Sato et al. Stem Cells Translational Medicine
- Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
- (2011) Dagmar Beier et al. Molecular Cancer
- MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
- (2011) Atsushi Sato et al. STEM CELLS
- Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
- (2010) T Kato et al. GENE THERAPY
- Advances in the Treatment of Malignant Gliomas
- (2010) Mustafa Khasraw et al. Current Oncology Reports
- Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
- (2009) Hiroaki Ikushima et al. Cell Stem Cell
- Heat Shock Protein 90 Is Important for Sp1 Stability during Mitosis
- (2009) Shao-An Wang et al. JOURNAL OF MOLECULAR BIOLOGY
- Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells
- (2009) Shigeo Ohba et al. JOURNAL OF NEURO-ONCOLOGY
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphorylation by c-Jun NH2-terminal Kinase 1 Regulates the Stability of Transcription Factor Sp1 during Mitosis
- (2008) Jian-Ying Chuang et al. MOLECULAR BIOLOGY OF THE CELL
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation